Market Place
Sourcing Support
Mylan`s Generic Lopinavir and Ritonavir Receives Approval in the U.S.
07 Feb 2024 //
FDA
Cipla, DNDi launch 4-in-1 antiretroviral treatment for young children with HIV
14 Jun 2022 //
EXPRESS PHARMA
Laurus` Generic Lopinavir & Ritonavir Receives Approval in the U.S.
21 Mar 2022 //
FDA
A giant trial of COVID-19 treatments is restarting
06 Aug 2021 //
SCIENCEMAG
Hetero Labs Ltd Iii`s Generic Lopinavir; Ritonavir Receives Approval In US
04 Jun 2021 //
FDA
Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results
03 Dec 2020 //
NEJM
Repurposed drugs not effective treatment for hospitalised COVID-19, WHO says
20 Oct 2020 //
EUROPEANPHARMACEUTICALSREVIEW
Gilead refutes WHO’s claim over remdesivir’s efficacy
19 Oct 2020 //
KOREABIOMED
Gilead’s COVID-19 drug Veklury falls short in WHO’s global trial
16 Oct 2020 //
PHARMAPHORUM
Pharming announces enrolment of first patient in multinational trial RUCONEST®
10 Aug 2020 //
PRNEWSWIRE
Older, critically ill patients with COVID-19 may increased risk bradycardia
10 Jul 2020 //
SCIENCEDAILY
Why lopinavir and hydroxychloroquine do not work on COVID-19
10 Jul 2020 //
SCIENCEDAILY
WHO discontinues hydroxychloroquine and lopinavir/ritonavir treatment arms
06 Jul 2020 //
WHO
Vaccines will need to beat placebo by 50% to qualify for FDA OK
30 Jun 2020 //
ENDPTS
No clinical benefit from use of lopinavir-ritonavir in hospitalised COVID-19
30 Jun 2020 //
RECOVERYTRIAL
Coronavirus: Hydroxychloroquine trial to restart
30 Jun 2020 //
BBC
Antiviral hyped as potential Covid treatment "ineffective", finds major study
29 Jun 2020 //
ECONOMICTIMES
After Kaletra setback, AbbVie joins forces for COVID hopeful pe
08 Jun 2020 //
FIERCE BIOTECH
Cipla to explore multi-drug combination with remdesivir for Covid-19
18 May 2020 //
PHARMACEUTICAL-TECHNOLOGY
Cipla working on multiple therapies to fight spread of coronavirus
18 May 2020 //
BUSINESS-STANDARD
Cipla working on multiple therapies to fight spread of coronavirus
17 May 2020 //
BUSINESS-STANDARD
UK spent £20m buying up stocks of HIV and malaria drugs
14 May 2020 //
THEGUARDIAN
Triple drug combination shows promise in Covid-19 treatment
11 May 2020 //
CLINICALTRIALSARENA
CSIR submits 53 genome sequences of coronavirus to global body
06 May 2020 //
ECONOMICTIMES
Traumakine to be a part of WHO’s Solidarity trial
27 Apr 2020 //
CISION
HIV And Flu Drugs Prove Futile In Fight Against Coronavirus
22 Apr 2020 //
FORBES
In Russia, a black market for HIV drug to try on coronavirus
21 Apr 2020 //
REUTERS
Positive results from initial lopinavir-ritonavir COVID-19 clinical trial
08 Apr 2020 //
CLINICALTRIALSARENA
Mylan waives exclusive US distribution rights for potential COVID-19 therapy
26 Mar 2020 //
REUTERS
Mylan Announces Additional Efforts to Support Response to the COVID-19 Pandemic
25 Mar 2020 //
MYLAN
Chloroquine, Kaletra and a flu drug disappoint in COVID-19 tests
25 Mar 2020 //
FIERCE PHARMA
AbbVie waives all worldwide restrictions on making generic copies of Kaletra HIV pill
24 Mar 2020 //
STATNEWS
COVID-19: CMA, NIHR, AbbVie updates
20 Mar 2020 //
PHARMATIMES
HIV drug combo fails as treatment for severe COVID-19 in China study
20 Mar 2020 //
REUTERS
RGICD awaits ICMR nod to prescribe ARV drugs lopinavir & ritonavir
18 Mar 2020 //
PHARMABIZ
Can old drugs take down a new coronavirus?
13 Mar 2020 //
C&EN
Lannett Announces Approval For Lopinavir & Ritonavir Oral Solution
03 Jan 2017 //
PR NEWSWIRE
Silarx’s Generic Lopinavir & Ritonavir Receives Approval In US
27 Dec 2016 //
FDA
In snit over supply, MSF urges South Africa to override AbbVie drug patent
03 Nov 2015 //
FIERCE PHARMA
Government exempts AIDS drugs from customs duty
10 Jun 2015 //
THE ECONOMIC TIMES
Cipla`s Generic lopinavir/ritonavir (40mg/ 10 mg) Approved in US For HIV in Infants
09 Jun 2015 //
CIPLA
